APA

Bond A., Probert C., . (20200101). Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. : Alimentary pharmacology & therapeutics.

Chicago

Bond Ashley, Probert Chris, . 20200101. Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. : Alimentary pharmacology & therapeutics.

Harvard

Bond A., Probert C., . (20200101). Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. : Alimentary pharmacology & therapeutics.

MLA

Bond Ashley, Probert Chris, . Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. : Alimentary pharmacology & therapeutics. 20200101.